Market icon
Clima E Ciência·Pandemias

CDC emite aviso de Nível 3 até 31 de dezembro?

Market icon
Clima E Ciência·Pandemias

CDC emite aviso de Nível 3 até 31 de dezembro?

dez 31

dez 31

Sim

54% acaso
Polymarket

$96,271 Vol.

Sim

54% acaso
Polymarket

$96,271 Vol.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 56.5% probability that the CDC will issue a Level 3 "Avoid Nonessential Travel" warning by December 31, driven by recent escalations in global outbreaks prompting multiple Level 2 notices, including meningococcal disease in the Democratic Republic of the Congo's Kongo Central Province (issued March 24, 2026) and yellow fever surges across Venezuela (March 16). These reflect heightened transmission risks in regions with limited healthcare infrastructure, alongside ongoing Level 2 alerts for chikungunya in Mayotte, Suriname, Bolivia, and Seychelles, and clade II mpox in Ghana and Liberia. No Level 3 notices are active, but H5N1 avian influenza's 71 U.S. human cases since 2024—mostly mild, exposure-linked—and the emerging SARS-CoV-2 BA.3.2 "Cicada" variant in 25 states underscore epidemiological vigilance. Weekly CDC surveillance updates and potential case surges could tip thresholds for Level 3 designation.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$96,271
Data de Término
31 dez 2026
Mercado Aberto
Jan 19, 2026, 3:15 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus on Polymarket implies a 56.5% probability that the CDC will issue a Level 3 "Avoid Nonessential Travel" warning by December 31, driven by recent escalations in global outbreaks prompting multiple Level 2 notices, including meningococcal disease in the Democratic Republic of the Congo's Kongo Central Province (issued March 24, 2026) and yellow fever surges across Venezuela (March 16). These reflect heightened transmission risks in regions with limited healthcare infrastructure, alongside ongoing Level 2 alerts for chikungunya in Mayotte, Suriname, Bolivia, and Seychelles, and clade II mpox in Ghana and Liberia. No Level 3 notices are active, but H5N1 avian influenza's 71 U.S. human cases since 2024—mostly mild, exposure-linked—and the emerging SARS-CoV-2 BA.3.2 "Cicada" variant in 25 states underscore epidemiological vigilance. Weekly CDC surveillance updates and potential case surges could tip thresholds for Level 3 designation.

This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.

The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$96,271
Data de Término
31 dez 2026
Mercado Aberto
Jan 19, 2026, 3:15 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if the CDC issues a Level 3 (“Reconsider Nonessential Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution. The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.

Cuidado com os links externos.

Frequently Asked Questions

"CDC emite aviso de Nível 3 até 31 de dezembro?" is a prediction market on Polymarket with 2 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "O CDC emite alerta de Nível 3 até 31 de dezembro?" at 56%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 56¢ implies that the market collectively assigns a 56% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "CDC emite aviso de Nível 3 até 31 de dezembro?" has generated $96.3K in total trading volume since the market launched on Jan 19, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "CDC emite aviso de Nível 3 até 31 de dezembro?," browse the 2 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "CDC emite aviso de Nível 3 até 31 de dezembro?" is "O CDC emite alerta de Nível 3 até 31 de dezembro?" at 56%, meaning the market assigns a 56% chance to that outcome. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "CDC emite aviso de Nível 3 até 31 de dezembro?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.